Friday, July 10, 2020
Sign inJoin

Govt takes away drug pricing power from pharmaceutical companies 

ISLAMABAD: The federal government has put an end to the power of pharmaceutical companies to increase prices of drugs while not paying...

Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine

LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million...

Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh

Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh. Clarifying its position, the...

Pharmaceuticals may turn to Chinese raw material as tensions with India soar

Pakistan has formulated a strategy to deal with any crisis arising out of an embargo on the import of raw material supplied...

Trump vows to reduce US drug prices to world’s lowest

WASHINGTON: US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug...

Pakistan’s biggest pharma deal in advanced talks: report

Businessman Munis Abdulla to purchase one of OBS Group's pharmaceutical operations for a reported sum of Rs11bn Pakistan's OBS Group is in...

OBS Pakistan amalgamates AGP with AitkenStuart

It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.

Medicinal imports rise 3.54pc to $929m

ISLAMABAD: Pakistan has imported medicinal products worth $929.355 million during the first ten months of the current fiscal year, showing a growth of...

Pharma industry decides to slash prices of 395 essential drugs

'Prices will not increase if rupee remains stabilised, utility prices are maintained and rate of inflation is controlled'  KARACHI: Pakistan Pharmaceutical Manufacturers' Association...

Pakistan’s medicinal imports rise by 9.74pc

ISLAMABAD: Pakistan imported medicinal product worth $656.092 million during the first seven months of current fiscal year, showing growth of 9.74 per...

Can Hamdard thrive in the era of the millennial consumer?

It is an ad that relies on contrasts: a product as traditionally Pakistani as Hamdard’s Rooh Afza being consumed by non-Pakistanis in...

Govt decision to increase medicine prices augurs well for domestic drugmakers: Fitch Solutions

Revenue generating opportunities for local pharmaceutical companies in Pakistan will improve following the decision by the government to increase the prices of medicines, said Fitch Solutions

IPO proceeds in 2018 plunged by 49% to Rs4.8 billion

AGP Pharmaceutical, one of the largest companies in the country’s pharmaceutical sector via its offer for sale (OFS) collected 65% of total raised capital during 2018

Sanofi-Aventis Pakistan’s sole shareholder to transfer its shareholding to subsidiary Zentiva NV

LAHORE: Sanofi-Aventis Pakistan (Ltd) on Friday announced that the sole shareholder of SECIPE, i.e. Sanofi S.A. has made a decision to disincorporate...

Oxfam’s damning report puts multinational pharma companies in the dock over tax evasion

Tax Dodgers: In seven developing countries, firms appeared to avoid an estimated $112m in taxes every year ISLAMABAD: Oxfam International’s damning report confirmed...